Jon Edelson

​Jon Edelson, MD, has been Chairman, CEO & President since the company's inception in January 2016. Dr. Edelson has over 25 years of experience starting and running health care companies, including Anterios, which he led through its acquisition by Allergan, and Advanced Health which he led through initial and secondary public stock offerings. As CEO, Dr. Edelson previously also co-founded venture-backed Aureon Biosciences and Physicians’ Online, the latter of which was acquired by Mediconsult.com. Prior to this, as CEO, Dr. Edelson founded Medical Decision Resources, which was acquired by prescription benefit manager ValueRx. Dr. Edelson was a board member for Covagen AG, a Swiss biopharmaceutical company until its acquisition by Johnson & Johnson. Dr. Edelson has been awarded multiple patents for his inventions. In prior years, Dr. Edelson has been the lead author for articles published in peer-reviewed medical journals such as the Journal of the American Medical Association. Dr. Edelson received a BA (summa cum laude) from Yale University and an MD (with honors) from the University of Chicago. Dr. Edelson attended the Harvard School of Public Health and was a Dana Scholar at the University of Pennsylvania School of Medicine. Dr. Edelson was Board Certified in Internal Medicine after completing his training at Harvard’s Brigham & Women’s Hospital.